Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Personalized intermittent fasting routines found b...
The efficacy of patient-tailored Intermittent Fasting (IF) regimens holds promising results to combat Metabolic Dysfunction-Associated Steatotic...
Ancient meets Modern: Breakthrough treatment with...
Combining the time-tested efficacy of Traditional Chinese Medicine with contemporary pharmaceutical therapy, Yalan Chen et al. have introduced a...
2 minFDA nods for Resmetirom, first-of-its-kind liver s...
Resmetirom is now FDA-approved for non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosi...
3 minLinaclotide found effective for functional constip...
A recent clinical trial in ‘Journal of Pediatric Gastroenterology and Nutrition’ investigated the effectiveness and safety of Li...
1 minStudy finds Tegoprazan 50 mg effective for functio...
A recent prospective multicenter clinical trial evaluated the efficacy and safety of tegoprazan, a potassium-competitive acid blocker (P-CAB), in...
1 minErythrocyte sedimentation rate and C-reactive prot...
Published in the Chinese Journal of Contemporary Pediatrics, this study evaluated the significance of various endoscopic scoring methods for asse...
1 minExploring potential Hepatitis B treatment choices:...
Rui Liu et al. scrutinized the efficacy of two leading treatments: Tenofovir alafenamide (TAF) and Tenofovir disoproxil fumarate (DF) for chronic...
1 minVonoprazan-Amoxicillin duo with S. boulardii effec...
Adjunct therapy of Saccharomyces boulardii (S. boulardii) along with Vonoprazan-amoxicillin dual therapy offers new hope for Helicobact...
2 minMRI findings: Obesity linked to liver and kidney f...
Higher body weight or obesity (25 < body mass index (BMI) < 30) plays a crucial role in developing fatty liver and kidney conditions, concl...
2 minSafety and efficacy of Proton-pump inhibitors when...
To assess the effectiveness and safety of the Proton-pump inhibitors (PPIs) + Alginate compared to using PPIs monotherapy for...
2 minTegoprazan for functional dyspepsia: A multicenter trial on effic...
Tegoprazan (50 mg), a potassium-competitive acid blocker, is effective and safe for treating functional dyspepsia, offering prominent symptom rel...
Statins cut fibrosis risk in MASLD patients: New findings!
Both high and moderate-intensity statins show a protective effect against fibrosis deterioration in MASLD.
Tongxieyaofang eases IBS through CHRM3 regulation and gut barrier...
The decoction of Tongxieyaofang alleviates irritable bowel syndrome symptoms by influencing CHRM3 and gut barrier function.
Evaluation of antimicrobial concentrations in gastric tissues for...
Optimizing the levels and distribution of antibacterial drugs in the gastric mucosa is crucial for achieving effective H. pylori elimination rate...
Study reveals new findings for erosive esophagitis therapy
Potassium-competitive acid blockers are safe and effective, especially for 2-week short-term use, severe erosive esophagitis, and maintenance the...
Fexuprazan offers superior gastritis relief in two weeks compared...
Fexuprazan outperforms Rebamipide in treating acute gastritis over two weeks and matches its effectiveness over four weeks, thereby offering quic...
Long-term mortality in alcohol-related liver disease: Insights fr...
Patients with alcohol-related liver disease face a high risk of death due to liver disease long after diagnosis, with specific cancers like hepat...
Study: Tirzepatide for fight against steatohepatitis and liver fi...
Tirzepatide notably improves liver condition and fibrosis outcomes, and warrants consideration for inclusion in treatment strategies.
Do lifestyle changes lower the risk of mortality in NAFLD patient...
Adopting a healthy lifestyle drastically lowers all-cause and cardiovascular mortality risks in patients with nonalcoholic fatty liver disease, w...
Dialysis fatigue and recovery time remain unaffected by PPIs
Proton pump inhibitors do not affect recovery time or fatigue in hemodialysis patients, confirming their safety in managing these symptoms.
Xiangsha Liujunzi effective and safe for functional dyspepsia
Gastrointestinal health can be improved with Xiangsha Liujunzi decoction which enhances motility, protects the mucosa, and moderates inflammation...
Serum Angpt-2: Key diagnostic biomarker for diabetic kidney disea...
Serum Angiopoietin-2 shows immense potential as an early marker for diabetic kidney disease in children, supporting its future therapeutic prospe...
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.